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Introduction
The misregulation of polarized transport within epithelial cells 
can result in a loss of apico-basolateral polarity. The impor-
tance of this cellular asymmetry is clear, as its loss is the first 
step of the epithelial-to-mesenchymal transition (EMT; Townsend 
et al., 2008), which in addition to being a critical developmental 
mechanism, is also a well-established prerequisite for tumori-
genesis and metastasis (Wang et al., 2008a; López-Novoa and 
Nieto, 2009; Strizzi et al., 2009). The appropriate regulation of 
epithelial polarity depends on the regulation of endocytic and 
biosynthetic transport routes. Consequently, polarized transport 
is a very complex process that is highly regulated throughout 
development and tissue morphogenesis (Zurzolo et al., 1992). 
The plasma membrane (PM) of epithelial cells is separated into 
the apical and basolateral domains, distinct in both lipid and 
protein composition. This asymmetry is essential for the proper 
function of these specialized cells, which line the internal face of 
many organs and act as a barrier between the internal and exter-
nal environments of the organism. The “holy grail” of epithelial 
organogenesis is to determine how individual cells are capable 
of coordinating and acting as a multicellular unit with a defined 
architecture that enables this organ to carry out complex pro-
cesses that are beyond the capabilities of any single cell.
The formation of the apical lumen is a key step in organo-
genesis, required for the establishment of the organ’s architec-
ture, and thereby its function. Although there is a high degree 
of morphogenetic diversity between organisms, the end result 
of lumen formation is always a structure in which the apical 
surface of the cell is facing the epithelial lumen. Thereby, the 
establishment and expansion of the apical lumen is a key step 
during tissue morphogenesis. Much effort has been dedicated 
to deciphering the machinery responsible for the establishment 
and expansion of the epithelial lumen, with one of the more 
recent areas of interest being apical targeting, which has been 
shown to play a key role in the establishment of the epithe-
lial lumen during development (Lubarsky and Krasnow, 2003;   
Martin-Belmonte and Mostov, 2008).
As the result of work from many laboratories, we are be-
ginning to decipher the machinery that mediates lumen formation 
D
uring the morphogenesis of the epithelial lumen, 
apical proteins are thought to be transported via 
endocytic compartments to the site of the forming 
lumen, although the machinery mediating this transport 
remains to be elucidated. Rab11 GTPase and its binding 
protein, FIP5, are important regulators of polarized endo-
cytic transport. In this study, we identify sorting nexin 18 
as a novel FIP5-interacting protein and characterize the 
role of FIP5 and SNX18 in epithelial lumen morphogene-
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SNX18 to tubulate membranes, which implies a role for 
FIP5 and SNX18 in endocytic carrier formation and/or 
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like all Rab GTPases, works via the recruitment and activation 
of its effector proteins, we set out to elucidate the role of FIPs in 
mediating epithelial lumen formation. Previous studies have 
shown that FIP5, a member of the FIP family of proteins, is 
required for transcytosis of the polymeric IgA receptor (pIgA-R)   
in filter-grown MDCK cells (Prekeris et al., 2000). Because 
transport of apical PM proteins during lumen formation resem-
bles transcytosis, we decided to test whether FIP5 may also be 
involved in the transport and targeting of apical membrane pro-
teins during lumen formation. First, we tested the localization 
of FIP5 in 3D cultures of polarized MDCK cysts. As shown in 
Fig. 1 (D–F), FIP5 localizes to the apical domain of the cysts, 
although some FIP5 staining can also be observed close to the 
basolateral PM. Similarly, in rat kidney proximal tubules, FIP5 
is enriched at the apical pole of the cells (Fig. 1, G and H). This 
localization in both 2D and 3D cultures is fully consistent with 
the  observed  staining  of  FIP5  in  filter-grown  MDCK  cells, 
where FIP5 is enriched in the endosomal organelles close to the 
apical PM (Fig. 1, A–C). Furthermore, in filter-grown MDCK 
cells, FIP5 partially colocalizes with the pIgA-R but not the 
transferrin receptor (TfR; unpublished data), which is consis-
tent with a role for FIP5 in apically directed protein transport.
FIP5 knockdown disrupts lumen 
morphogenesis during the formation  
of epithelial cysts
To  further  understand  the  role  of  FIP5  in  epithelial  lumen   
morphogenesis, we used the pHUSH conditional short hair-
pin RNA (shRNA) system (Gray et al., 2007) to create a tetra-
cycline (tet)-inducible FIP5 shRNA-expressing MDCK cell line 
(MDCK-shFIP5). The use of tet-inducible shRNA allows us to 
knock down FIP5 expression before or after the formation of 
epithelial cysts, thus separating the roles of FIP5 in the estab-
lishment and maintenance of the epithelial lumen. As shown 
in Fig. S1 (A and B), incubation of MDCK-shFIP5 cells with 
1 µg/ml doxycycline (dox) resulted in the specific depletion of 
FIP5 by >85% while having no effect on the expression of other 
FIPs, such as FIP1. Interestingly, after FIP5 knockdown, filter-
grown cells were still able to form tight junctions, as observed 
by the unchanged trans-epithelial resistance and localization   
of the tight junction marker Occludin (Fig. S1 C). We also per-
formed transferrin (Tf) basolateral recycling assays, and have 
shown that FIP5 knockdown had no significant effect on the 
rate or fidelity of basolateral endocytic recycling (Fig. S1 D). 
Thus, filter-grown MDCK cells lacking FIP5 are capable of po-
larization and the formation of intact epithelial monolayers.
To test whether FIP5 is required for epithelial lumen mor-
phogenesis, we grew MDCK-shFIP5 cells in Matrigel 3D cul-
tures to allow for the development of polarized epithelial cysts. 
As shown in Fig. 2 (A and C), after 12 d, untreated MDCK-
shFIP5 cells formed normal epithelial cysts with a single lumen   
that is surrounded by a monolayer of polarized cells. In con-
trast, upon FIP5 knockdown, the resulting cysts have multiple 
lumens that are surrounded in some areas by several layers of 
cells (Fig. 2, B, D, and E). The phenotype could be rescued 
by the expression of shRNA-resistant FIP5-GFP (Fig. 2 E), 
which demonstrates that multiple lumens are the result of FIP5 
during tissue morphogenesis. One model, proposed by Dr. Mostov 
and colleagues, suggests that at the single-cell stage, the apical 
domain markers, such as glycoprotein 135 (gp135) and Crumbs3, 
are localized at the PM facing the ECM (Martin-Belmonte and 
Mostov, 2008; Schlüter et al., 2009; Bryant et al., 2010). After 
initial cell division, apical proteins are endocytosed and are 
transported to the site of the forming apical lumen. Here, apical 
cargo–containing transport vesicles fuse with the PM to initiate 
the formation and expansion of the apical lumen. The identity 
of these apical cargo–containing transport vesicles remains to 
be fully understood. Originally they were referred to as vacuo-
lar apical compartments (VACs), as they contain apical PM 
protein gp135. However, recent work has shown that these or-
ganelles also contain Rab11 and Rab8 GTPases, and thus likely 
represent a subpopulation of apical recycling endosomes (Bryant 
et al., 2010). We will henceforth refer to these organelles as 
gp135-containing endosomes.
The machinery that targets gp135-containing endosomes 
to the site of the forming apical lumen involves interplay be-
tween  multiple  proteins  (Bryant  et  al.,  2010).  Among  such 
proteins, Rab11 plays a key role in regulating the polarized 
transport (Desclozeaux et al., 2008; Bryant et al., 2010). How-
ever, the precise molecular mechanisms mediating Rab11 func-
tion remain to be determined. It is thought that Rab11 binding 
to specific effector proteins is vital for determining Rab11’s 
functions, as well as its specificity for individual endocytic re-
cycling pathways. Rab11 family interacting proteins (Rab11-
FIPs, referred to henceforth as FIPs) were identified as Rab11 
effector proteins (Prekeris et al., 2000; Hales et al., 2001). FIPs 
serve as scaffolds that recruit specific sets of endocytic proteins. 
One member of the FIP family, FIP5 (also known as Rip11), is 
required for protein targeting to the apical PM (Prekeris et al., 
2000). A potential role of FIP5 in mediating Rab11-dependent 
apical lumen formation has never been investigated and is the 
focus of these studies. Here, we investigate the mechanism of 
lumen formation and demonstrate that gp135 is transported via 
apical recycling endosomes, a process that is dependent on the 
FIP5. Furthermore, we identify sorting nexin 18 (SNX18) as a 
FIP5-binding protein, and demonstrate that interaction between 
these proteins regulates membrane tubulation in vitro, as well 
as epithelial lumen formation in vivo, while having no effect 
on basolateral protein transport. Thereby, we propose that the 
FIP5, via interaction with SNX18, mediates the formation and 
transport  of  gp135-containing  endosomes,  and  consequently 
plays a role in the establishment of a single lumen during epi-
thelial cyst morphogenesis.
Results
FIP5 is a Rab11-effector protein that is 
enriched in apical recycling endosomes  
in polarized epithelial cysts
The establishment of the epithelial lumen is a complex pro-
cess known to depend on Rab11 GTPase (Desclozeaux et al., 
2008), as well as on the polarized transport of apical proteins 
(Vega-Salas et al., 1987; Davis and Bayless, 2003; Kamei et al., 
2006; Martin-Belmonte and Mostov, 2008). Because Rab11, 73 SNX18 is a FIP5-binding protein • Willenborg et al.
presence of multiple lumens in knockdown cysts (unpublished 
data). To test whether FIP5 knockdown cells form tight junc-
tions in 3D cultures, we used anti-cingulin antibody to visual-
ize tight junctions. As shown in Fig. 2 I, after FIP5 depletion, 
3D cysts could still form tight junctions, although these tight 
junctions are now found to be associated with each of the mul-
tiple lumens.
FIP5 is required for gp135  
targeting during early stages  
of apical lumen formation
Although our data demonstrate that FIP5-mediated transport 
is required for epithelial lumen formation, it remains unclear 
whether FIP5 is required for the establishment of the lumen or 
for its maintenance after the polarization of the epithelial cyst 
has occurred. Although the mechanisms of epithelial lumen 
knockdown rather than off-target effects. To determine whether 
cells in FIP5-lacking cysts still polarize, we stained control and 
dox-treated cysts with antibodies against gp135. Glycoprotein 
135 (gp135) is a 135-kD cell surface membrane protein that 
has been found to localize to the apical pole of MDCK cells, 
where it is thought to associate with the actin cytoskeleton and 
is a hallmark of the apical PM in epithelial cells. As shown in 
Fig. 2 F, control cysts contain a single lumen outlined by anti-
gp135 staining. In contrast, in FIP5 knockdown cysts, gp135 
marks the presence of multiple lumens (Fig. 2 G). To further 
confirm that dox-treated cells form multiple lumens, we also 
tested the localization of ezrin. Ezrin is a well-characterized 
member of the ezrin-radixin-moesin (ERM) family of proteins 
shown to concentrate on the apical surface of polarized epi-
thelial cells. Consistent with our observation that FIP5 regu-
lates lumen formation, anti-ezrin staining also confirmed the 
Figure 1.  FIP5 is enriched at the apical pole of polarized epithelial cells. (A–F) MDCK cells were grown in 2D (A–C) or 3D (D–F) cultures. Cells were fixed 
with 4% paraformaldehyde and stained with anti-FIP5 (A–F, green), anti-Occludin (A–C, red) or anti–e-Cadherin (D–F, red) antibodies. In A–C, images 
were taken at the apical, tight junction and basolateral levels of polarized MDCK cells. (G and H) Rat kidney sections were stained with anti-FIP5 antibody. 
In H, antibody was preincubated with a 20-fold excess of purified recombinant FIP5. Bars: (A–F) 8 µm; (G and H) 10 µm.JCB • VOLUME 195 • NUMBER 1 • 2011   74
that is situated at the center of the dividing cells with the   
basolateral proteins facing the ECM, with FIP5 staining con-
centrated around the site of the initiated lumen (Fig. S2, G–J).
Protein transport to the apical membrane resembles trans-
cytosis of the pIgA-R that occurs in filter-grown MDCK cells. 
Because FIP5 is known to be required for transcytosis and   
is  localized  to  the  site  of  the  forming  lumen  (Fig.  S2,   
E and H), we tested whether FIP5 may be required for trans-
port of gp135 to the apical PM. MDCK-shFIP5 cells were pre-
incubated for 74 h in the presence or absence of dox, seeded, 
allowed to grow for 24 h in 3D cultures, then imaged to ana-
lyze the cysts at the two- and four-cell stages. As shown in 
Fig. 3 (A, B, C, and H), in the FIP5-depleted cells, only 20% of the 
cysts at the four-cell stage had formed a single lumen, as com-
pared with 70% of the control cysts. In the remaining 80% of 
FIP5-depleted cysts, half endocytosed gp135, but these gp135-
containing endosomes accumulated at multiple sites within 
the cells (Fig. 3, C and H). In the other half of the cells, gp135 
was still present at PM as well as inside the organelles scat-
tered throughout the cytosol (Fig. 3, G and H; and not de-
picted).  Interestingly,  when  we  added  dox  after  the  initial 
establishment remain to be fully understood, one existing model 
proposes that in the early stages of MDCK cell lumen morpho-
genesis, apical proteins are localized in the PM facing the ECM 
(Martin-Belmonte and Mostov, 2008; Schlüter et al., 2009). At 
the two/four cell stage, the apical proteins are transported to the 
site of the forming apical lumen (known as apical membrane 
initiation site [AMIS]). Fusion of these transport organelles 
initiates lumen formation and establishes the apical-basolateral 
polarity of the cyst (Martin-Belmonte and Mostov, 2008). Con-
sistent with this model, at the two-cell stage, almost 40% of cysts 
displayed gp135 at the PM domain facing the ECM (Fig. S2,   
A–C and J). At this stage, FIP5 is localized to punctate organ-
elles that are diffusely scattered throughout the cell (Fig. S2,   
B and C). In the remaining 60% of forming cysts, gp135 was 
localized to the area of cell–cell contact, with the basolateral 
proteins facing the ECM (Fig. S2, D–F; and Fig. 3 J). These 
cells likely represent the initial stages of lumen formation after 
the inversion of polarity. By this stage, FIP5 also concentrates 
at the site of the forming lumen between the cells and exhibits 
a substantial overlap with gp135 staining (Fig. S2, E and F).   
By the four-cell stage, >80% of cysts have formed a single lumen   
Figure 2.  FIP5 is required for the formation of a single lumen in 3D epithelial cysts. (A–E) MDCK-shFIP5 cells were grown for 9 d in the presence (B and D)   
or absence (A and C) of 1 µg/ml of dox. Cells were then fixed with 4% paraformaldehyde, stained with Hoechst DNA stain, and imaged by bright-field 
(A and B) or fluorescence (C and D) microscopy. E shows the quantitation of epithelial cysts with single lumen. Data shown are the means and standard 
deviations derived from three independent experiments (error bars). n is the total number of cysts analyzed. Insets show dox+ cyst expressing FIP5-GFP.   
(F–I) MDCK-shFIP5 cells were grown for 9 d in the presence (G and I) or absence (F and H) of 1 µg/ml of dox. Cells were then fixed with 4% paraformal-
dehyde and stained with anti-gp135 (F and G) or anti-cingulin (H and I) antibodies. Bars: (A and B) 40 µm; (C and D) 8 µm; (E) 16 µm (F–I) 8 µm.75 SNX18 is a FIP5-binding protein • Willenborg et al.
FIP5 is required for scission  
of the endocytic carriers from  
recycling endosomes
Although our data demonstrate the involvement of FIP5 in the 
transport of apical proteins and the formation of the apical   
lumen, it remains unclear what stage of membrane traffic is de-
pendent on FIP5. To gain insight into whether FIP5 regulates 
endocytic carrier formation, budding, transport, or fusion, we 
transduced HeLa cells with a FIP5 dominant-negative mutant 
(GFP-FIP5-F1, also known as GFP-Rip11-F1) and analyzed en-
dosomal morphology by EM. GFP-FIP5-F1 is the GFP-tagged 
C-terminal end of FIP5, which contains the Rab11-binding do-
main. This mutant has previously been shown to act as a strong 
lumen had been formed (24 h after seeding), we observed no 
defects in single apical lumen maintenance (Fig. 3 I).
Multiple lumen formation can be the result of the fail-
ure of the AMIS formation or of defects in delivery/fusion of 
gp135-containing endosomes. Because tight junction proteins 
have been shown to be a marker for the AMIS at the two-cell 
stage, we stained cells grown in the presence or absence of dox 
with anti-cingulin and anti-gp135 antibodies. As shown in Fig. 3 
(D–G), FIP5 depletion did not have any effect on AMIS for-
mation. In summary, these results indicate a role for FIP5 in 
regulating the transport of gp135-containing endosomes to the 
AMIS during the initiation of the epithelial lumen, but no role 
in lumen maintenance.
Figure 3.  FIP5 is required for the establishment of the apical lumen during the early stages of epithelial cyst formation. (A–G) MDCK-shFIP5 cells were 
grown for 74 h in the presence (C, F, and G) or absence (A, B, D, and E) of 1 µg/ml of dox to pre-knockdown FIP5. Cells were then seeded in 3D cultures 
and grown for 24 h. Cells were fixed with 4% paraformaldehyde and stained with anti-gp135 (A–C, E, and G, green), anti-cingulin (D–G, red), or anti-
FIP5 (B, red) antibodies. (H) The quantitation of 3D cyst polarization at the two and four cell stages from the experiment shown in A–F. Data shown are the 
means and standard deviations derived from three independent experiments. n is the number of cysts analyzed. (I) The quantitation of fully matured (9 d) 
epithelial cysts with a single lumen in cells incubated with or without 1 µg/ml of dox supplementation beginning 24 h after seeding in 3D cultures. Data 
shown are the means and standard deviations derived from three independent experiments (error bars). n is the number of cysts analyzed. Insets show the 
extent of FIP5 (green) knockdown in the presence of doxycycline. Bars: (A–G) 8 µm; (I) 20 µm.JCB • VOLUME 195 • NUMBER 1 • 2011   76
of Tf-HRP, whereas others appear to completely lack Tf-HRP 
(Fig. 4, C and D, asterisks). This uneven Tf-HRP distribution 
within a single endosome suggests that overexpression of the 
FIP5 dominant-negative mutant allows for cargo sorting, but 
may block the scission of endocytic carriers, thus resulting in 
this beads-on-a-string phenotype. Consistent with this hypoth-
esis, the majority of GFP-FIP5-F1 appears to be localized to the 
necks between the beads, as well as to the necks of the forming 
buds at the ends of the endosomal tubules (Fig. 4 B).
SNX18 is a FIP5-binding protein
Recent studies demonstrate that FIP family members function 
as scaffolding proteins that recruit various mediators of mem-
brane transport to the recycling endosomes. To identify poten-
tial FIP5-binding proteins, we immunoprecipitated FIP5 from 
HeLa cells using anti-FIP5 antibody (Fig. 5 A). The protein 
bands present only in the anti-FIP5 antibody lane, and not in the 
IgG control lane, were cut out and analyzed by mass spectrom-
etry (Fig. 5 A). The corresponding areas from the IgG control 
were also cut out and analyzed as negative controls. Only pro-
teins that were identified by at least two different peptides 
solely in the anti-FIP5 immunoprecipitate were considered as 
potential FIP5-binding proteins. Interestingly, proteomic analysis 
dominant-negative  inhibitor  by  dimerizing  with  endogenous 
FIP5 and inhibiting its cellular functions (Junutula et al., 2004). 
Because FIP5 has been shown to play a role in Tf recycling in 
nonpolarized HeLa cells (Schonteich et al., 2008), we loaded 
HeLa cells (for 45 min at 37°C) with Tf-HRP to identify recy-
cling endosomes. As shown in Fig. 4 A (right), overexpression 
of GFP-FIP5-F1 caused extensive accumulation of tubulated 
membrane-bound  organelles,  which  are  likely  recycling  endo-
somes, as they contain Tf-HRP. Interestingly, most of these 
tubular endosomes exhibited a “beads-on-a-string” phenotype 
and were often extended along microtubules (Fig. 4, C–F). The 
association of these endosomes with microtubules is consistent 
with previous observations that FIP5 also binds Kinesin II and 
regulates endosomal transport along microtubules. Furthermore, 
the putative Kinesin II binding domain is located within FIP5’s 
C terminus (Schonteich et al., 2008), thus allowing GFP-FIP5-F1 
to interact with Kinesin II. A similar, although less dramatic, 
beads-on-a-string phenotype was also observed in HeLa cells 
transfected with FIP5, but not FIP1, siRNAs (Fig. S3, A and B; 
and not depicted).
Perhaps the most interesting observation is that Tf-HRP 
was not evenly distributed within the GFP-FIP5-F1–induced 
beads-on-a-string endosomes, as some “beads” contain high levels 
Figure  4.  FIP5  is  required  for  the  scission 
of endocytic carriers at recycling endosomes. 
(A) Control (left) and GFP-FIP5-F1–expressing 
(right) HeLa cells were incubated with Tf-HRP 
for 45 min at 37°C. Cells were then fixed and 
prepared for ultrastructural EM analysis. Electron-
dense dark precipitate indicates DAB reaction 
product  and  highlights  the  localization  of 
Tf-HRP. (B) GFP-FIP5-F1–expressing HeLa cells 
were incubated with Tf-HRP for 45 min at 37°C. 
The DAB reaction was performed before per-
meabilization, antibody incubation, and fixa-
tion. Electron-dense dark precipitate indicates 
the DAB reaction product and highlights the lo-
calization of Tf-HRP, whereas 10 nm gold par-
ticles indicate the localization of GFP-FIP5-F1 
(arrows).  (C–F)  Higher-magnification  images   
from  HeLa  cells  expressing  GFP-FIP5-F1  and 
loaded with Tf-HRP. Asterisks and arrows in   
C and D point to the “bead” that lacks Tf-HRP, 
whereas arrowheads track nearby microtubules. 
Bars: (A) 5 µm; (B–F) 200 nm.77 SNX18 is a FIP5-binding protein • Willenborg et al.
Figure 5.  SNX18 is FIP5-binding protein. (A) FIP5 was immunopreciptated from HeLa cell lysates with anti-FIP5 antibody. The immunoprecipitate was then 
separated by SDS-PAGE and stained with Coomassie dye. Proteins listed in the figure were identified by at least two peptides from the anti-FIP5 immuno-
precipitate, and were not present in the IgG control. (B) Human SNX18 sequence. Boxed regions indicate the peptides identified in proteomic analysis of 
the immunoprecipitate from A. (C) SNX18 or FIP5 were immunoprecipitated from MDCK cell lysates and immunoblotted with anti-SNX18, anti-FIP5, and 
anti-SNX9 antibodies. (D) HeLa cells were cotransfected with myc-SNX18 and FIP5-GFP. Cells were lysed, and myc-SNX18 was immunoprecipitated with 
anti-myc antibodies and blotted with anti-SNX18 and anti-GFP antibodies. (E) Schematic representation of the domains present in SNX9 and SNX18 pro-
teins. Numbers between the SNX9 and SNX18 schematics indicate the percentage of homology between the corresponding domains of these proteins.JCB • VOLUME 195 • NUMBER 1 • 2011   78
SNX18 bind with an apparent Kd of 1.56 µM (Fig. 6, A and B). 
The binding appears to be specific to FIP5, as SNX18 interacts 
with other FIP family members with considerably lower affinity 
(Fig. 6, B and C). To test whether Rab11 regulates FIP5 binding 
to SNX18, purified recombinant FIP5 was incubated with GST-
SNX18 beads in the presence or absence of Rab11-GTP. As 
shown in Fig. 6 C, Rab11-GTP had no effect on the interaction 
between FIP5 and GST-SNX18, which suggests that FIP5 can 
interact with Rab11 and SNX18 simultaneously. Surprisingly, 
FIP5 also bound to GST-SNX9, which suggests that FIP5 can 
bind in vitro to at least two members of the SNX9/18/33 family. 
To test if FIP5 binds to SNX9 and SNX18 via the same domain, 
we tested whether SNX9 and SNX18 compete for binding to 
FIP5. As shown in Fig. 6 D, soluble SNX9 inhibited binding 
of FIP5 to GST-SNX18 beads. Furthermore, our competition   
assay suggests that the affinity of SNX9 binding to FIP5 appears 
to be similar to that of SNX18 binding to FIP5 (Fig. 6 D).
To further characterize the interaction between FIP5 and 
SNX18, a series of SNX18 truncation mutants were created 
to determine the site of FIP5 binding to SNX18. The binding 
site was narrowed to a region of 20 amino acids (aa 180–200), 
which reside within the LC region of SNX18 (Fig. 6 D). Inter-
estingly, SNX18’s LC domain contains a conserved binding 
sequence for Arp2/3, called the “A-like domain,” that is also 
found in SNX9 (Shin et al., 2008), as well as the site for inter-
action with the AP-1 complex (Håberg et al., 2008), with both of 
these sites located outside of the FIP5 binding region (aa 180–
200). Because Arp2/3 and AP-1 have both been implicated in 
identified the clathrin heavy chain and SNX18 as FIP5-associating 
proteins (Fig. 5, A and B). To confirm that SNX18 and FIP5 are 
part of the same protein complex in vivo, anti-SNX18 and anti-
SNX9 antibodies were generated (Fig. S3, C and D). These 
antibodies demonstrated that FIP5 coimmunoprecipitates from 
MDCK cell lysates with anti-SNX18 but not anti-SNX9 anti-
bodies (Fig. 5 C and not depicted). Furthermore, FIP5-GFP co-
immunoprecipitates with myc-SNX18 from cells coexpressing 
FIP5-GFP and myc-SNX18 (Fig. 5 D).
SNX18 is one of >30 members of the SNX family of pro-
teins, many of which have been identified as regulators of endo-
cytic cargo sorting and vesicle formation. SNX family proteins 
are peripheral membrane proteins that are characterized by the 
presence of a Phox-homology (PX) domain, which binds phos-
phatidylinositides (PIs) on membrane surfaces. SNX18, along 
with its highly similar homologues SNX9 (depicted in Fig. 5 E)   
and SNX33, are part of a subfamily of SNXs that contain a 
BAR domain that binds to phospholipids and induces curvature 
in membranes, thus aiding in tubule and vesicle formation. The 
SNX9/18/33 family members are highly homologous to each 
other with the exception of the low complexity (LC) region 
(Fig. 5 E). SNX9, SNX18, and SNX33 were shown to have 
distinct subcellular localizations, and are thought to regulate 
different stages of endocytic trafficking, although recent work 
has shown that there may be some redundancy between SNX9 
and SNX18 (Park et al., 2010). To further characterize the inter-
action between FIP5 and SNX18, we performed isothermal 
titration calorimetry (ITC). ITC analysis shows that FIP5 and 
Figure 6.  FIP5 binds to SNX18-LC domain. 
(A  and  B)  The  affinity  of  FIP5  and  SNX18 
binding as determined by ITC. N.D., not de-
tected.  (C)  Glutathione  beads  were  coated 
with GST-SNX18, GST-SNX9, or GST alone 
and incubated with 6His-FIP5 or 6His-FIP3 in 
the presence or absence of a fivefold excess of 
Rab11a-GTP. The amount of bound 6His-FIP3 
or 6His-FIP5 was determined by immunoblot-
ting  with  anti-FIP3  or  anti-FIP5  antibodies.   
(D) Glutathione beads were coated with GST-
SNX18  or  GST  alone  and  incubated  with 
6His-FIP5 in the presence of increasing con-
centrations of soluble recombinant SNX9. The 
amount of bound 6His-FIP5 was determined 
by immunoblotting with anti-FIP5 antibodies. 
(E) Schematic representation of the FIP5-binding 
domain in SNX18 as determined by glutathi-
one bead pull-down assays.79 SNX18 is a FIP5-binding protein • Willenborg et al.
different PIs in a seemingly nondiscriminatory manner. This 
observation is consistent with previous findings that the PX do-
mains of SNX9 and SNX18 exhibit little selectivity for various 
PIs (Di Paolo and De Camilli, 2006; Pylypenko et al., 2007; 
Håberg et al., 2008).
Because  FIP5  contains  a  C2  domain,  which  was  sug-
gested to bind lipids (Lindsay and McCaffrey, 2004), the abil-
ity of FIP5 to bind liposomes containing various PIs was 
analyzed (Fig. 7, A and B). Consistent with previous findings, 
FIP5 did bind to liposomes, an interaction that is mediated by 
its C2 domain (Fig. 7 B). However, in contrast to previous data 
(Lindsay and McCaffrey, 2004), no selectivity for specific lipid 
composition was detected (Fig. 7 A). The disparity in the re-
sults of these two binding assays may result from the present 
studies being direct liposome-binding assays, whereas previ-
ous work used protein–phospholipid overlay assays.
Next we tested whether FIP5 binding affects the ability 
of SNX18 to bind lipids. To this end, we incubated SNX18 
the regulation of endocytic budding, it is possible that SNX18 
binding to FIP5 may be required for the formation and/or scis-
sion of endosomal carriers.
FIP5 induces SNX18-dependent  
tubulation of liposomes
SNX18 and SNX9, being BAR domain–containing proteins 
known to bind phospholipids and induce curvature in mem-
branes, likely contribute to tubule/vesicle formation and scis-
sion. Indeed, it was shown that SNX9 can tubulate liposomes 
in vivo and is required for AP-2 and clathrin-dependent bud-
ding and scission at the PM. Because SNX18 was shown to 
bind to AP-1, we postulated that SNX18 may play a similar 
role to SNX9 at the endosomes. The in vitro binding of SNX18 
to liposomes was evaluated and showed that SNX18 readily 
binds liposomes (Fig. 7 A). Because SNX18 contains a PX   
domain, the ability of SNX18 to bind different PIs was tested. 
As shown in Fig. 7 A, SNX18 binds to liposomes containing 
Figure  7.  FIP5 induces SNX18- and SNX9-
dependent  liposome  tubulation.  (A)  SNX18 
or FIP5 were incubated with PS/PC liposomes 
containing various phosphatidylinositides. Lipo-
somes  were  then  sedimented  and  levels  of 
bound  SNX18  or  FIP5  were  determined  by 
Coomassie  staining.  (B)  C-  (FIP5  C-terminal) 
or N-terminal (FIP5-C2) domains of FIP5 were 
tested for their ability to bind PS/PC liposomes 
containing 5% PI(4,5)P2. The levels of bound 
proteins were determined by Coomassie stain-
ing. (C) SNX18 was incubated with PS/PC/
PI(4,5)P2 liposomes in the presence or absence 
of GST-FIP5. The levels of bound SNX18 and 
GST-FIP5  were  determined  by  Coomassie 
staining. Black lines indicate the removal of   
intervening lanes for presentation purposes. 
(D) EM analysis of liposomes incubated with 
GST, GST-SNX9, GST-SNX18, 6His-FIP3, and   
6His-FIP5. Arrows point to wide tubules (122.1 ±   
32.9  nm,  n  =  10)  and  arrowheads  point   
to narrow tubules (54.1 ± 18.1nm, n = 10). 
The  asterisk  marks  short  tubules  induced  by 
SNX18 alone.JCB • VOLUME 195 • NUMBER 1 • 2011   80
localized to perinuclear organelles (Fig. S4 H). These organelles 
are likely recycling endosomes, as they could be labeled with 
Tf–Alexa Fluor 495 (Tf-Alexa495; Fig. S4, I–K). Interestingly, 
although GFP-SNX18 and Tf-Alexa495 were both present on 
some of the endocytic organelles, they were often enriched in 
different recycling endosomal subdomains (Fig. S4, I–K; GFP-
SNX18  domains  are  marked  by  arrowheads).  Thus,  SNX18 
may be required for the sorting and/or budding of specialized 
cargo while having no role in the trafficking of the TfR. To test 
this hypothesis, we analyzed Tf uptake and recycling dynam-
ics in HeLa cells transfected with SNX18 siRNA (Fig. S5 F).   
Consistent with our localization data in HeLa cells, we see no 
effect of SNX18 knockdown on either Tf uptake (Fig. S5 F) or 
its recycling (not depicted).
Because SNX18 appears to regulate endocytic transport 
of specialized cargo, we speculated that in polarized cells it 
may mediate apical protein targeting during lumen formation. 
To that end, a tet-inducible SNX18 shRNA-expressing MDCK 
cell line (MDCK-shSNX18) was created. As shown in Fig. S5 
(A–C), after incubation with dox for 96 h, this cell line knocks 
down SNX18 by >85%, while having no effect on SNX9 levels. 
Just as with the FIP5 shRNA-expressing cell line, filter-grown 
SNX18-depleted cells can still form a polarized monolayer with 
intact tight junctions, as observed by anti-Occludin staining and 
an unchanged trans-epithelial electrical resistance (Fig. S5 D). 
Furthermore, consistent with our data using HeLa cells, the 
knockdown of SNX18 had no significant effect on the rate or 
fidelity of the Tf receptor’s recycling in MDCK cells (Fig. S5 E). 
To determine whether SNX18 is required for proper epithelial 
lumen morphogenesis, MDCK-shSNX18 cells were grown in 
3D cultures and allowed to develop into mature cysts. After 9 d,   
70% of untreated MDCK-shSNX18 cells formed normal cysts 
with a single lumen (Fig. 8, A and B), whereas 75% of SNX18 
knockdown cysts were disorganized, mispolarized in areas, and 
formed multiple lumens (Fig. 8, A and B). This phenotype can be 
rescued by expressing shRNA-resistant myc-SNX18 (Fig. 8 B).   
To test whether SNX18 is also required for the early stages of 
lumen formation, we imaged 3D cultures 12 h after plating to 
determine whether SNX18 knockdown has any effect on the 
initiation of lumen formation. Although 80% of control cysts 
formed a single lumen (Fig. 8, C and E), 75% of SNX18-
depleted cells formed cysts with multiple lumens, with only 
25% of knockdown cysts forming a single lumen (Fig. 8, C 
and E). If dox was added after the initial formation of the apical 
lumen, SNX18 knockdown had a much smaller, although sta-
tistically significant, effect on the expansion and maintenance 
of single lumens (Fig. 8 D). These data collectively imply that 
SNX18, like FIP5, is involved in the establishment of a single 
apical lumen during the formation of epithelial cysts.
Discussion
Polarized membrane trafficking is critical for the morphogene-
sis of the apical lumen in epithelial cells (Lubarsky and Krasnow, 
2003; Martin-Belmonte and Mostov, 2008). Rab11 GTPase has 
been shown to regulate endocytic recycling in the polarized epi-
thelia and is thought to be involved in apical-directed transport 
with  1,2-dipalmitoyl-glycero-3-phosphoserine  (PS)/1-palmitoyl-2-
oleoyl-glycero-3-phosphocholine (PC)/l--phosphatidyinositol-
4,5-bisphosphate  (PI(4,5)P2)  liposomes  in  the  presence  or 
absence of GST-FIP5. As shown in Fig. 7 C, the addition of 
GST-FIP5 had no effect on SNX18 association with liposomes 
in vitro. Similarly, FIP5 depletion in MDCK cells had no   
effect on SNX18’s subcellular localization (unpublished data), 
which suggests that FIP5 and SNX18 are initially recruited to 
membranes independently from each other.
Because both SNX18 and FIP5 are capable of indepen-
dently binding liposomes, the capacity of SNX18 and FIP5 to in-
dependently or coordinately tubulate liposomes was evaluated. 
Interestingly, although SNX18 alone was capable of inducing 
a small number of membrane tubules (Fig. 7 D), preincubation 
of SNX18 with FIP5 resulted in a much greater degree of lipo-
some tubulation (Fig. 7 D). Interestingly, SNX18 coincubation 
with FIP5 resulted in liposome tubules of two distinct sizes. 
The larger tubules (122.1 ± 32.9 nm, n = 10) were shorter and 
often  connected  nontubulated  liposomes,  thus  resembling  a 
beads-on-a-string  phenotype  (Fig.  7  D,  arrows).  In  contrast, 
thinner tubules (54.1 ± 18.1 nm, n = 10) were longer and usu-
ally not connected to round liposomes (Fig. 7 D, arrowheads). 
Finally, consistent with in vitro binding experiments, liposomes 
incubated with SNX9 and FIP5 also showed a higher degree of 
tubulation as compared with SNX9 alone (Fig. 7 D). In con-
trast,  SNX18  incubated  with  FIP3  did  not  induce  liposome   
tubulation, nor did GST or FIP5 alone (Fig. 7 D). These results 
indicate a role for FIP5 as an activator of SNX9/18’s tubulating 
activity that may play a role in the formation and/or scission of 
endocytic transport carriers.
SNX18 localizes to endocytic 
compartments and is required for  
lumen morphogenesis
The  subcellular  localization  of  proteins  often  provides  clues 
about their potential functions. Unfortunately, published studies 
about the localization of SNX18 have been controversial.   
Håberg et al. (2008) have demonstrated that in HeLa cells, 
SNX18 is present on endosomes and may regulate endocytic 
transport. In contrast, recently published work suggested that 
SNX18 has redundant functions with SNX9, and may actually 
work with and localize to the PM (Park et al., 2010). To further 
understand the subcellular distribution of SNX18, we analyzed 
the  localization  of  SNX18  in  filter-grown,  polarized  MDCK 
cells. As shown in Fig. S4 (A–D), the majority of endogenous 
SNX18 was localized in the cytosol and on endosome-like or-
ganelles, rather than at the PM. This data support the hypothesis 
that SNX18 may aid in mediating vesicle budding and/or scis-
sion in endosomes. Note that, unlike FIP5, in 2D- or 3D-grown 
MDCK cells, SNX18 was not only present on apical endosomes, 
but could also be detected on basolaterally located organelles 
(Fig. S4). Thus, it is possible that SNX18 regulates basolateral 
endocytic transport steps in addition to apical transport.
In addition to MDCK cells, we compared the localization 
of SNX18 and SNX9 in HeLa cells. As shown in Fig. S4 G,   
GFP-SNX9  was  predominately  localized  to  multiple  puncta 
present at the PM. In contrast, GFP-SNX18 was predominately 81 SNX18 is a FIP5-binding protein • Willenborg et al.
Figure 8.  SNX18 is required for the establishment of the apical lumen at the early stages of epithelial cyst formation. (A and B) MDCK-shSNX18 cells were 
grown for 9 d in the presence (A-c and A-d) or absence (A-a and A-b) of 1 µg/ml of dox. Cells were then fixed with 4% paraformaldehyde and stained 
with anti-gp135 (A-a and A-c) or anti-cingulin (A-b and A-d) antibodies. B shows the quantitation of epithelial cysts with a single lumen. Data shown are 
the means and standard deviations derived from three independent experiments (error bars). n is the number of cysts analyzed. Insets show dox+ cyst 
expressing myc-SNX18. (C–E) MDCK-shSNX18 cells were grown for 74 h in the presence (C-c, C-d, and C-f) or absence (C-a, C-b, and C-e) of 1 µg/ml 
of dox to pre-knockdown SNX18. Cells were then seeded in 3D cultures and grown for 24 h. Cells were fixed with 4% paraformaldehyde and stained 
with anti-gp135, anti-cingulin, or anti-SNX18 antibodies. E shows the quantitation of 3D cyst polarization at the two and four cell stages of the experiment 
shown in C. Data shown are the means and standard deviations derived from three independent experiments. n is the number of cysts analyzed. (D) The 
quantitation of fully matured (9 d) epithelial cysts with a single lumen in cells incubated with or without 1 µg/ml of dox added after 24 h in 3D cultures. 
Data shown are the means and standard deviations derived from three independent experiments (error bars). n is the number of cysts analyzed. Insets show 
the extent of SNX18 (green) knockdown in the presence of dox. Bars: (A) 8 µm; (B) 16 µm; (C) 3 µm; (D) 16 µm.JCB • VOLUME 195 • NUMBER 1 • 2011   82
(for review see Prekeris, 2003). Recent studies have also impli-
cated Rab11 in mediating the proper establishment and expansion 
of the apical lumen (Desclozeaux et al., 2008). Rab11 functions by 
interacting with and recruiting several effector proteins (Prekeris, 
2003; Tarbutton et al., 2005). Here we demonstrate that FIP5, a 
known Rab11 effector protein (Prekeris et al., 2000), is required 
for the initial formation of the apical lumen by regulating the 
formation and scission of gp135-containing transport vesicles 
from apical recycling endosomes. We also show that FIP5 
functions by binding and activating SNX18, a BAR domain–
containing  protein  involved  in  membrane  remodeling.  This 
work, in combination with a recently published study from 
Bryant et al. (2010), demonstrates that the Rab11 GTPase me-
diates epithelial tissue morphogenesis by sequentially regulat-
ing the generation, targeting, and fusion of gp135-containing 
endosomes to the AMIS during the initiation of lumen formation.
Rab11 forms mutually exclusive complexes with various   
FIPs (Meyers and Prekeris, 2002), a process thought to allow 
Rab11 to function in many distinct endocytic recycling pathways. 
Because FIP5 is an apically localized protein that is required for   
transcytosis to the apical PM, we hypothesized that FIP5 may regu-
late gp135 transport during the formation of the apical lumen. In-
deed, the knockdown of FIP5 results in the formation of multiple 
lumens, while having no effect on the fidelity or kinetics of the ba-
solateral transport of the TfR. The formation of multilumen cysts 
is an indication of defects in either the initiation or expansion/
maintenance of the apical lumen. The generation of tet-inducible 
shRNA cell lines allows us to test whether FIP5 is required during or 
after lumen formation. Interestingly, although the depletion of FIP5 
during the formation of the apical lumen resulted in multilumenal 
epithelial cysts, FIP5 knockdown after the initiation of the lumen   
had little effect on epithelial cyst organization. These data suggest 
that FIP5 may only play a minor role in the expansion and main-
tenance of the apical lumen and are mainly required for the apical 
lumen initiation.
Figure 9.  Proposed model of the roles of FIP5 and SNX18 in apical lumen 
formation and endosomal scission.
Our  proteomics  data  identified  SNX18  as  a  putative 
FIP5-interacting protein, a finding that is further supported by 
our pull-down and ITC assays. Because SNX9/18/33 family 
member proteins contain a BAR domain and are implicated 
in transport carrier formation/scission, this interaction sug-
gests a potential role for SNX18 and FIP5 in the formation 
of endocytic carriers on apical recycling endosomes. It was 
previously suggested that in nonpolarized cells, SNX18 is 
localized to and functions in endocytic organelles (Håberg 
et al., 2008), although this suggestion remains controversial. 
Consistent with this hypothesis, we show that SNX18 is capa-
ble of liposome tubulation in vitro. Pre-incubation of SNX18 
with FIP5 results in a further increase in liposome tubula-
tion, arguing for a role of FIP5 in the activation of SNX18. 
Indeed, it was previously shown that the overexpression of 
full-length SNX18 and SNX9 results in less tubulating activ-
ity as compared with the overexpression of only the PX-BAR 
domains (Håberg et al., 2008). Recent studies also suggested 
that the SH3 domain of SNX9 interacts with the SNX9-BAR 
domain in vitro (Wang et al., 2008b). Thus, it is likely that 
SNX18 is autoinhibited by the SNX18-SH3 domain binding to   
the SNX18-BAR domain. Afterwards, the binding of FIP5 
to the LC region of SNX18 likely results in the opening and   
activation  of  SNX18.  Consistent  with  the  involvement  of 
FIP5 in endocytic carrier scission, overexpression of the FIP5   
dominant-negative  mutant  results  in  the  tubulation  of  en-
dosomes  and  the  formation  of  endocytic  beads-on-a-string 
structures. Because inhibition of FIP5 would prevent the acti-
vation of endocytic SNX18, this beads-on-a-string phenotype 
is likely caused by the failure of the scission of endocytic 
carriers from the recycling endosomes. Indeed, most of the 
gold labeling for the FIP5 mutant was localized to the necks 
of the beads and buds, which are the likely scission sites of 
the forming endocytic carriers.
The physical and functional association between FIP5 and 
SNX18 brings up the possibility that SNX18 and FIP5 function 
together  during  epithelial  lumen  morphogenesis.  Consistent 
with this, knockdown of SNX18 leads to a multilumen pheno-
type. Furthermore, SNX18 is also predominantly required dur-
ing the early stages of lumen formation, and its knockdown 
leads to a phenotype similar to the one resulting from FIP5 
knockdown. Collectively, our data suggest that FIP5 binding to 
SNX18  induces  SNX18-BAR  domain-dependent  membrane 
bending, and that SNX18 activation is required for the forma-
tion and/or scission of gp135-containing transport vesicles at 
apical recycling endosomes.
Surprisingly, our data show that in vitro, FIP5 also inter-
acts with SNX9 with an affinity that is similar to SNX18 bind-
ing. Furthermore, liposome assays show that FIP5 binding also 
induces SNX9-dependent membrane tubulation. Although we 
cannot rule out the possibility that FIP5 interacts with SNX9 
in vivo, it is not likely that this interaction plays any role in medi-
ating protein transport from apical recycling endosomes to the 
apical PM. Multiple studies have shown that SNX9 localizes   
to the PM, where it regulates protein endocytosis. In contrast, 
FIP5 is associated with apical recycling endosomes (Fig. 1; 
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although this  remains  to  be  demonstrated  (Fig.  9).  Newly 
formed transport organelles are then targeted to the apical PM, 
possibly via Rab11 binding to the Exocyst complexes (Fig. 9; 
Bryant et al., 2010). Recent studies have shown that Rab11-de-
pendent apical transport also results in the activation of Cdc42 
and the formation of the Par3–Par6 complex (McCaffrey and 
Macara, 2009; Bryant et al., 2010), both known regulators of 
cortical epithelial polarity. Additionally, FIP5 is known to bind 
Kinesin II (Schonteich et al., 2008), providing a link to a poten-
tial mechanism for the transport and targeting of FIP5-positive 
vesicles. Although the full picture of the interactions involved 
in lumen morphogenesis has yet to be completed, emerging data 
suggest that Rab11 and its binding proteins play a key role in 
integrating apical transport and epithelial PM polarization dur-
ing tissue morphogenesis.
Materials and methods
Antibodies
Rabbit  polyclonal  anti-SNX18  antibodies  were  prepared  as  described 
previously (Prekeris et al., 2000) using recombinant purified human full-
length SNX18. Antibodies were affinity purified using recombinant SNX18 
conjugated to Affigel (Bio-Rad Laboratories) and eluted with 0.1 M glycine   
buffer, pH 2.5. Rabbit anti-FIP5, anti-FIP1, and anti-FIP3 polyclonal anti-
bodies have been described previously (Prekeris et al., 2000; Peden   
et al., 2004; Wilson et al., 2005). Mouse monoclonal anti-TfR, anti-Ezrin, 
and anti–e-Cadherin antibodies were obtained from BD. Rabbit anti-GFP 
was obtained from Invitrogen. 10 nm gold-conjugated anti–rabbit IgG 
was purchased from British BioCell International. Mouse monoclonal anti- 
Occludin antibody was obtained from Invitrogen. Mouse monoclonal anti-
gp135 antibody was a gift from C. Yeaman (University of Iowa, Iowa 
City, IA) and G. Ojakian (State University of New York Downstate Medical 
Center, Brooklyn, NY). Rabbit polyclonal anti-cingulin antibody was pro-
vided by S. Citi (University of Geneva, Geneva, Switzerland). Anti-endolyn 
antibodies were a gift from O. Weisz (University of Maryland, College 
Park, MD). Fluorescein-labeled anti–rabbit IgG antibody, Texas red– 
labeled anti-mouse IgG antibody, and goat anti–mouse AffiniPure F(ab’)2 
fragments were obtained from Jackson ImmunoResearch Laboratories, Inc. 
Cell-permeant Hoechst DNA stain and Tf conjugated to Alexa Fluor 594 
were obtained from Invitrogen.
Expression constructs and protein purification
SNX18, all SNX18 truncation mutants, and SNX9 (provided by D. Yarar, 
Whitehead Institute, Massachusetts Institute of Technology, Cambridge, 
MA) were expressed as GST fusion proteins using the pGEX-KG plasmid 
(GE Healthcare). GST fusion constructs were expressed and purified using 
the BL21-(FE3)-RIPL Escherichia coli strain as described previously (Junutula 
et al., 2004). In brief, E. coli were lysed using a French press and then in-
cubated with glutathione agarose beads (Sigma-Aldrich). Beads were then 
washed and either eluted with 25 mM glutathione or cleaved with throm-
bin (GE Healthcare).
Full-length human FIP3 and FIP5 were tagged with an N-terminal 6His 
tag followed by a tobacco etch virus cleavage site by subcloning into the 
baculovirus transfer vector, pVL1392. Cotransfection and amplification of 
recombinant baculovirus was conducted using BacPAK transfection reagents 
(BD) according to the manufacturer’s instructions. In brief, 10
6 Sf9 cells were 
seeded into a 6-well plate, and the Bacfectin–DNA mixture was added drop-
wise. After 5 d, the P1 viral stock was harvested and further amplified to   
P2 and P3 stages. For protein production, 1L of Sf9 cells at 2 million cells/ml 
were infected with 2 ml of P3 viral stock (approximate MOI of 0.5) and har-
vested after 65 h. Cells were lysed in 50 mM Tris buffer, pH 7.5, containing 
300 mM NaCl, and the cleared lysate was loaded onto a Ni-NTA column. 
Eluted 6His-FIP3 was dialyzed overnight against buffer (50 mM Tris, pH 7.5, 
300 mM NaCl, and 5 mM BME) and frozen in liquid nitrogen. Yields were 
typically 3–5 mg/liter with an estimated purity of >75%.
Generation and purification of adenovirus expression constructs
shRNA-resistant FIP5-GFP and myc-SNX18 adenoviral constructs and 
recombinant  adenovirus  were  generated  using  the  AdEasy  system   
(He et al., 1998). In brief, each gene was cloned into pShuttle-CMV, 
regulate Tf endocytosis, FIP5 knockdown has no effect on the 
rate of Tf uptake at the PM (Schonteich et al., 2008). It is likely 
that within the cell, differences in the spatial distribution be-
tween SNX9 and SNX18 ensure that FIP5 binds only to SNX18. 
Indeed, FIP5 and SNX18 interact only with micromolar affin-
ity, which is too low for the recruitment of SNX18 to mem-
branes in a FIP5-dependent manner. Thus, lipid binding–mediated 
recruitment of SNX18 at the recycling endosomes would be   
required to allow interaction with FIP5. Consistent with this, 
FIP5 knockdown did not affect SNX18’s localization to endo-
somes, and binding to FIP5 had no effect on the efficiency of 
SNX18 binding to liposomes in vitro. What remains unclear is 
how the specificity of SNX18’s recruitment to endosomes is 
regulated, as SNX18’s PX domain does not differentiate be-
tween different phosphatidylinositides.
In addition to FIPs, Rab11 binds several other effector   
proteins. Some of them, such as the Exocyst complex and Rabin8, 
were also implicated in mediating Rab11-dependent targeting   
and fusion of gp135-containing endosomes with the apical PM 
(Bryant et al., 2010). What remains unclear is how Rab11 inter-
actions  with  FIPs,  Rabin8,  and  the  Exocyst  complexes  are 
regulated. Structural studies of FIPs and Sec15 show that they 
all bind Rab11 switch motifs (Wu et al., 2005; Eathiraj et al., 
2006; Jagoe et al., 2006). Furthermore, because Rabin8 binds 
Rab11 in a GTP-dependent manner, it also likely interacts via 
the switch motif of Rab11 GTPase (Knödler et al., 2010). As a 
result, Rab11 should not be able to bind to Sec15, Rabin8, and 
FIP5 simultaneously. How then does Rab11 mediate the forma-
tion and targeting of gp135-containing endosomes? The likely 
scenario is that Rab11 sequentially binds to FIP5, Rabin8, and 
the Exocyst complex in a “hand-me-down” manner. Consistent 
with this, FIP5 and the Exocyst mediate different steps of api-
cal transport. Although Rab11 binding to Sec15 is required for 
gp135 targeting to the apical PM (Bryant et al., 2010), our data 
suggest that FIP5 and SNX18 mediate gp135-containing en-
dosome formation/scission. Future studies will be needed to 
understand the mechanisms that regulate the sequential inter-
action of Rab11 GTPase with multiple effector proteins during 
apical transport.
In summary, we propose that during lumen morphogen-
esis, apical proteins are internalized from the basolateral PM 
and are transported to apical recycling endosomes. There, api-
cal proteins are sorted into specialized transport organelles that 
carry cargo to the site of the forming apical lumen. Rab11 plays 
a key role in regulating multiple steps of this transport pathway. 
First, the formation/scission of these carriers is mediated by the 
interaction between the Rab11 effector protein, FIP5, and its 
binding partner SNX18. This binding initiates the process that 
leads to the activation of SNX18 and the induction of endocytic 
membrane bending (Fig. 9). Recent studies have also impli-
cated Arp2/3 (Shin et al., 2008) and N-WASP as SNX9 binding 
proteins that mediate endocytosis. Interestingly, SNX18 shares 
SNX9’s conserved Arp2/3 binding “A-like” domain, as well as 
its N-WASP binding domain, potentially allowing SNX18 to 
act as a site of interaction with the actin cytoskeleton. Thus, 
it is possible that SNX18 activation by FIP5 also leads to an 
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Cell culture and immunofluorescence microscopy
HeLa cells and MDCK-MIIR cells stably expressing human TfR and pIgA-R 
were cultured in DME with 4.5 g/liter glucose, 5.84 g/liter l-glutamine, 
and 10% heat-inactivated tet-free FBS (Takara Bio Inc.), and supplemented 
with 100 IU/ml penicillin and 100 µg/ml streptomycin.
For 2D filter cell culture assays, MDCK-MIIR cells were plated on 
collagen-coated 0.4 µm pore-size Transwell filters (Corning) and allowed 
to polarize for 4 d. Cells were then fixed with 4% paraformaldehyde for 
15 min and permeabilized for 10 min in PBS containing 0.4% saponin, 
and nonspecific sites were blocked with PBS containing 0.2% BSA and 
1% FBS. Cells were incubated with specific antibodies, washed in PBS, 
and mounted in VectaShield (Vector Laboratories). Cells were imaged with 
an inverted Axiovert 200M deconvolution microscope (Carl Zeiss) with a 
63× oil immersion lens and QE charge-coupled device camera (Sensicam). 
Image processing was performed using 3D rendering and exploration soft-
ware (Intelligent Imaging Innovations).
3D cell culture assays for cyst formation were conducted according 
to a previously described method (Vieira et al., 2006). In brief, actively 
dividing cells were mixed with growth factor reduced Matrigel (BD) and   
plated in 12-µl drops on 8-well slides. The Matrigel–cell mixture was   
allowed to harden for 30 min at 37°C, and 400 µl of medium was added. 
The cells were incubated for the indicated period of time and the media 
was changed every other day. 3D cell cultures were stained according to a 
modified previously published protocol (Debnath et al., 2003). In brief, 3D 
cultures were fixed with 3% paraformaldehyde for 20 min, permeabilized 
with PBS and 0.5% Triton X-100 for 10 min, and quenched three times 
for 15 min each wash with a glycine/PBS solution (130 mM NaCl, 7 mM 
Na2HPO4, 3.5 mM NaH2PO4, and 100 mM glycine). Cells were incubated 
in primary block (10% FBS, 130 mM NaCl, 7 mM Na2HPO4, 3.5 mM   
NaH2PO4, 7.7 mM NaN3, 0.1% BSA, 0.2% Triton X-100, and 0.05% 
Tween-20) for 4 h, followed by incubation in secondary block (primary 
block with 20 µg/ml goat anti–mouse F(ab’)2 fragments) for 1 h. After 
washing, cells were left overnight in primary block with primary antibody 
and Hoerscht nuclear stain. Cells were then washed and incubated for 1 h   
with secondary antibody in primary block. Cells were washed, dried for   
1 h, and mounted with VectaShield.
RNA interference
In HeLa cells, SNX18 was depleted with siRNA designed based on human 
SNX18 sequences (SNX18-1, 5-AATGTCAGACAGACGCGAAAA-3; 
SNX18-2, 5-AAGCACCTGACCTATGAGAAC-3). siRNAs were cotrans-
fected into HeLa cells using Lipofectamine2000 (Invitrogen). Transfected 
cells were incubated for either 48 or 74 h and analyzed for SNX18 
expression by Western blotting. Remaining cells were used for flow 
cytometry studies.
To create tet-inducible MDCK shRNA cells lines, SNX18 and FIP5 
shRNAs were designed using canine sequences (FIP5, 5-GATGAAGGGCA-
AGAAGAAG-3; SNX18, 5-ATCACAGATGCAGCATTC-3). shRNAs were 
then  cloned  into  the  pHUSH  retroviral  expression  vector  (provided  by   
D. Davis, Genentech, South San Francisco, CA). Stable, clonal cell lines were 
then selected using 1 µg/ml of puromycin and grown using regular MDCK 
media supplemented with tet-free FBS (Takara Bio Inc.). To knock down 
either SNX18 or FIP5, stable cells lines were incubated in the presence of 
1 µg/ml of dox for 72 h.
Analysis of Tf-biotin uptake and recycling in MDCK cells
MDCK cells expressing the human Tf receptor were grown on collagen-
coated 10 cm filters with a 0.4 µm pore size (10 mm filters; Corning). 
50 µg/ml of biotin-labeled human Tf (Sigma-Aldrich) was added to the 
basolateral chamber and allowed to internalize for 1 h at 37°C. The 
filters  were  then  washed  three  times  and  the  medium  was  replaced 
with  serum-supplemented  medium  containing  50  µg/ml  unlabeled   
human Tf, and cells were incubated for either 0 or 60 min at 37°C. The 
medium was collected at these time points and incubated for 30 min at 
room temperature with streptavidin-conjugated agarose resin (Thermo 
Fisher Scientific). The beads were washed five times with PBS, and the 
biotin-Tf was eluted by heating to 90°C for 10 min in the presence of 
1% SDS. Samples were separated by SDS-PAGE, followed by Western 
blot analysis using streptavidin conjugated to IRDye800 (LI-COR Bio-
sciences). Immunoblots were scanned and quantified using the Li-COR 
Odyssey Infrared Imager.
Analysis of Tf uptake in HeLa cells
For uptake assays, mock or SNX18 siRNA-treated HeLa cells were incubated 
with 20 µg/ml Tf-Alexa647 at 37°C for the indicated period of time. Cells 
were immediately pelleted, washed, and fixed for 20 min on ice in PBS with 
and the resultant clones were linearized with PmeI and used to transform   
E. coli BJ5183 cells carrying the viral DNA plasmid pAdEasy-1. Recom-
binant plasmids were digested with PacI to expose the inverted terminal 
repeats, and 8 µg of each construct was used to transfect, by calcium 
phosphate coprecipitation, 6-cm dishes of 50% confluent HEK 293 cells 
modified to express adenovirus preterminal protein, DNA polymerase, 
and DNA-binding protein. The medium was aspirated and replaced after 
24 h, and the cells were incubated for 10 d, until many plaques had 
formed. Virus was released by repeated freeze/thaw cycles and amplified 
by the addition of the adenoviral vector to fifty 10 cm dishes of HEK 293 
cells, which were incubated for 48 h. Virus harvesting and purification 
were conducted as described previously (Orlicky and Schaack, 2001). 
In brief, the cells were harvested by centrifugation, and the virus was 
released by three freeze/thaw cycles followed by centrifugation to pellet 
the cell debris. Two rounds of virus back-extraction were performed on the 
cell pellet. The supernatants were combined and purified via centrifuga-
tion on a cesium chloride step gradient of 1 ml of 1.4 g/c
2 and 2 ml of   
1.25 g/c
2 CsCl in PBS using an SW41 rotor centrifuged at 36,000 rpm. 
The virus banded at the interface of the CsCl steps, and was collected by 
side puncture with a syringe. The virus was next mixed with 1.35 g/c
2 
CsCl in PBS and centrifuged overnight at 65,000 rpm in an NVT100 
rotor, and again collected by syringe side puncture. The resulting puri-
fied virion-containing solution was dialyzed four times for 2 h each at   
4° against a modified previously published buffer containing 10 mM Tris,   
10 mM His, 75 mM NaCl, 1 mM MgCl2, 100 µM EDTA, 0.5% vol/vol 
EtOH, pH 7.4, and 50% vol/vol glycerol (Evans et al., 2004).
Virus particle concentrations were determined by OD260 spectropho-
tometry, with one OD260 unit equal to 10
12 particles. 30 plaque forming units/
cell were used for each experiment, as this was the amount of virus determined 
to result in the production of exogenous FIP5 or SNX18 equal to the amount of 
endogenous protein in dox
 cells (as determined by immunoblotting).
Glutathione bead pull-down assays
In glutathione bead pull-down assays, glutathione beads (50 µl) were coated 
with 10 µg of GST fusion protein or GST alone and incubated with varying 
amounts of soluble protein in a final volume of 0.5 ml of reaction buffer   
(50 mM Hepes, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 0.1% Triton X-100, 
0.1%  bovine  serum  albumin,  and  1  mM  phenylmethylsulfonyl  fluoride). 
Samples were incubated at 22°C for 1 h on a nutator with constant rotation. 
The samples were pelleted at 2,000 g for 3 min and washed three times with 
1 ml of reaction buffer. Bound proteins were eluted with 1% SDS, analyzed 
by SDS-PAGE, and either stained with Coomassie blue or immunoblotted.
Liposome preparation and tubulation analysis
All lipids were porcine brain lipid extract purchased from Avanti Polar   
Lipids, Inc. Liposomes were made from 90% PC, 5% PS, and 5% PI(4,5)P2.   
Lipids  were  mixed,  dried  under  a  nitrogen  stream,  and  lyophilized   
in vacuum for 2 h. Dried lipids were rehydrated in a solution of 25 mM 
Hepes, pH 7.5, 25 mM KCl, 2.5 mM magnesium acetate, and 150 mM 
potassium glutamate at room temperature for 1 h, after which the liposomes 
were sonicated for 30 min. GST, GST-SNX9, 6His-FIP3, GST-SNX18, or 
6His-FIP5 proteins were incubated with liposomes for 30 min at 37°C. 
Samples were immediately processed and analyzed via transmission elec-
tron microscopy. For electron microscopy analysis, samples were prepared 
using a modified previously published procedure (Farsad et al., 2001). In 
brief, 10 µl aliquots of liposome/protein incubations were adsorbed for   
5 min onto 250 µM hexagonal mesh copper grids (Electron Microscopy 
Sciences) and coated with 0.5% formvar solution in ethylene dichloride 
(Electron Microscopy Sciences) and carbon coated using an Auto 306 
Vacuum Coater (Edwards). Grids were stained with 1–2% uranyl acetate, 
blotted, washed with water, allowed to air dry, and imaged using a Techna 
G
2 12 transmission electron microscope (FEI Company) at 80 kV with Digi-
tal Micrograph 3.7.1 GMS1.2 imaging software (Gatan, Inc.).
ITC
ITC experiments were performed using a VP-ITC calorimeter (Microcal LLC) 
as recommended by the manufacturer. GST, GST-SNX18, or GST-SNX9 
were loaded in the sample cell (in PBS) and titrated with either 6His-FIP5 
or 6His-FIP3 proteins in the same buffer (10 µl injections up to a total of 
30 injections). The titrations were performed while samples were stirred at 
300 rpm at 25°C or at the indicated temperature. An interval of 4 min was 
allowed between each injection for the baseline to stabilize. The blank ITC 
titration was performed against buffer by injecting 6His-FIP5. The blank 
subtraction was done for all data used for analysis. The data were fitted via 
the one-set-of-sites model to calculate the binding constant (K) using Origin 
software (Microcal, LLC).85 SNX18 is a FIP5-binding protein • Willenborg et al.
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4% paraformaldehyde. Cells were sedimented and resuspended in PBS, and 
the amount of internalized Tf was determined by flow cytometric analysis. 
Flow cytometry analyses were performed using a Cytomics FC 500 flow 
cytometer (Beckman Coulter) equipped with 488-nm and 647-nm lasers.
Immunoprecipitation and proteomics
HeLa cell lysates from twenty 10-cm plates were harvested in the pres-
ence of 1% Triton X-100. Cell lysates were then incubated overnight 
with either 50 µg/ml lysate of affinity-purified rabbit anti-FIP5 antibody 
or 50 µg/ml lysate of purified nonspecific rabbit IgG, followed by the 
addition of 100 µl of protein A–Sepharose per 1 ml of lysate. Beads 
were then washed, eluted with 1% SDS, and separated on a 7–14% 
gradient  acrylamide  gel.  The  resulting  gel  was  Coomassie  stained 
and bands present only in the anti-FIP5 immunoprecipitate were iso-
lated. Gel bands were cut into three equal sections and in-gel digested   
using three proteases. Peptides were extracted from the gel pieces with   
0.1%  trifluoroacetic  acid/60%  acetonitrile  and  lyophilized.  Dried  pep-
tide samples from each gel band were rehydrated and loaded onto a 
microcapillary  column  (100  µm–inner  diameter  fused  silica)  packed   
with 15 cm Aqua C18 reverse-phase material, then placed in-line with an 
LTQ linear trap mass spectrometer. Peptides were eluted with a 2 h 
mobile gradient of acetonitrile/0.1% formic acid. Tandem mass spectra 
were analyzed via Sequest using a human/mouse/rat database concat-
enated to a randomized human/mouse/rat database. DTASelect was 
used to reassemble identified peptides into proteins. Identified proteins 
were filtered at <5% false discovery rate.
Lipid binding assays
In  lipid  binding  assays,  PC/PS  (90%:5%  at  a  final  concentration  of   
0.5 mg/ml) liposomes with or without phosphatidylinositides (at 5%) were in-
cubated for 30 min at room temperature with 5 µM of recombinant purified 
SNX18 or 6His-FIP5. Liposomes were then sedimented by centrifugation 
for 60 min at 50,000 rpm in a TLA100 rotor. Liposomes were resuspended 
in PBS with 1% SDS. Samples were then separated on SDS/PAGE gels, 
and the amount of bound protein was determined by Coomassie staining.
Electron microscopy analysis
For analysis of Tf localization, HeLa cells were transfected with or without 
GFP-FIP5-F1 and incubated with Tf-HRP 1:40 in L15 for 45 min at 37°C, 
48 h after transfection. The cells were then fixed with paraformaldehyde 
and glutaraldehyde before performing the DAB reaction, dehydration, and 
embedding, essentially as described by Stinchcombe et al. (1995). For   
immunolabeling, HeLa cells previously transfected with or without GFP-
FIP5-F1 (24 h) were loaded with Tf-HRP 1:40 in L15 for 45 min at 37°C, 
then chilled on ice. DAB labeling was performed using 3% DAB (TAAB) 
and 0.003% H2O2 (Sigma-Aldrich) in Tris/HCl 0.05 M, pH 7.6, for 30 min 
in the dark, followed by digitonin permeabilization, paraformaldehyde   
fixation, and incubation with rabbit anti-GFP antibody (1:1500) and 10 nm 
gold-conjugated anti–rabbit IgG antibody, essentially as described by Futter 
et al. (1998). Ultrathin sections (60-70 nm thick) were cut using a microtome 
(Ultracut E; Reichert-Jung), stained with lead citrate, and viewed using a 
CM12 transmission electron microscope (Phillips).
Online supplemental material
Figs. S1 and S5 show data characterizing MDCK cells expressing tet-
inducible FIP5 shRNA (Fig. S1) and SNX18 shRNA (Fig. S5). Fig. S2 
shows  the  images  characterizing  early  stages  (2–4  cells)  of  epithelial   
lumen formation. Fig. S3 contains additional EM images of cells expressing 
FIP5  siRNA,  as  well  as  characterization  of  new  anti-SNX18  and  anti- 
SNX9 antibodies. Fig. S4 shows subcellular localization of endogenous 
SNX18  as  well  as  GFP-tagged  SNX18  and  SNX9  in  HeLa  and  MDCK 
cells. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201011112/DC1.
We thank Dr. Brian Doctor (University of Colorado Denver) for critical reading 
of the manuscript. We are appreciative of Dr. Charles Yeaman and Dr. George 
Ojakian for anti-gp135 antibodies. We are also grateful to Dr. Defne Yarar 
for SNX9 and SNX18 cDNAs, and Dr. David Davis for the pHUSH expression 
vector. Finally, we thank Dr. O. Weisz for anti-endolyn antibodies and Dr. Sandra 
Citi for anti-cingulin antibodies.
This work was supported by a grant from the National Institutes of 
Health-NIDDK (DK064380 to R. Prekeris).
Submitted: 22 November 2010
Accepted: 7 September 2011JCB • VOLUME 195 • NUMBER 1 • 2011   86
Wu, S., S.Q. Mehta, F. Pichaud, H.J. Bellen, and F.A. Quiocho. 2005. Sec15 
interacts with Rab11 via a novel domain and affects Rab11 localization 
in vivo. Nat. Struct. Mol. Biol. 12:879–885. http://dx.doi.org/10.1038/ 
nsmb987
Zurzolo, C., C. Polistina, M. Saini, R. Gentile, L. Aloj, G. Migliaccio, S. Bonatti, 
and L. Nitsch. 1992. Opposite polarity of virus budding and of viral 
envelope glycoprotein distribution in epithelial cells derived from dif-
ferent tissues. J. Cell Biol. 117:551–564. http://dx.doi.org/10.1083/jcb 
.117.3.551
McCaffrey, L.M., and I.G. Macara. 2009. The Par3/aPKC interaction is essen-
tial for end bud remodeling and progenitor differentiation during mam-
mary gland morphogenesis. Genes Dev. 23:1450–1460. http://dx.doi.org/ 
10.1101/gad.1795909
Meyers, J.M., and R. Prekeris. 2002. Formation of mutually exclusive Rab11 
complexes  with  members  of  the  family  of  Rab11-interacting  pro-
teins regulates Rab11 endocytic targeting and function. J. Biol. Chem. 
277:49003–49010. http://dx.doi.org/10.1074/jbc.M205728200
Orlicky, D.J., and J. Schaack. 2001. Adenovirus transduction of 3T3-L1 cells.   
J. Lipid Res. 42:460–466.
Park, J., Y. Kim, S. Lee, J.J. Park, Z.Y. Park, W. Sun, H. Kim, and S. Chang. 
2010. SNX18 shares a redundant role with SNX9 and modulates endo-
cytic trafficking at the plasma membrane. J. Cell Sci. 123:1742–1750. 
http://dx.doi.org/10.1242/jcs.064170
Peden,  A.A.,  E.  Schonteich,  J.  Chun,  J.R.  Junutula,  R.H.  Scheller,  and  R. 
Prekeris.  2004.  The  RCP-Rab11  complex  regulates  endocytic  protein 
sorting.  Mol.  Biol.  Cell.  15:3530–3541.  http://dx.doi.org/10.1091/mbc 
.E03-12-0918
Prekeris, R. 2003. Rabs, Rips, FIPs, and endocytic membrane traffic. Scientific 
WorldJournal. 3:870–880. http://dx.doi.org/10.1100/tsw.2003.69
Prekeris, R., J. Klumperman, and R.H. Scheller. 2000. A Rab11/Rip11 pro-
tein  complex  regulates  apical  membrane  trafficking  via  recycling 
endosomes.  Mol.  Cell.  6:1437–1448.  http://dx.doi.org/10.1016/S1097- 
2765(00)00140-4
Pylypenko, O., R. Lundmark, E. Rasmuson, S.R. Carlsson, and A. Rak. 2007. 
The PX-BAR membrane-remodeling unit of sorting nexin 9. EMBO J. 
26:4788–4800. http://dx.doi.org/10.1038/sj.emboj.7601889
Schlüter, M.A., C.S. Pfarr, J. Pieczynski, E.L. Whiteman, T.W. Hurd, S. Fan, 
C.J. Liu, and B. Margolis. 2009. Trafficking of Crumbs3 during cyto-
kinesis is crucial for lumen formation. Mol. Biol. Cell. 20:4652–4663. 
http://dx.doi.org/10.1091/mbc.E09-02-0137
Schonteich,  E.,  G.M.  Wilson,  J.  Burden,  C.R.  Hopkins,  K.  Anderson,  J.R. 
Goldenring, and R. Prekeris. 2008. The Rip11/Rab11-FIP5 and kinesin II 
complex regulates endocytic protein recycling. J. Cell Sci. 121:3824–
3833. http://dx.doi.org/10.1242/jcs.032441
Shin, N., N. Ahn, B. Chang-Ileto, J. Park, K. Takei, S.G. Ahn, S.A. Kim, G. 
Di Paolo, and S. Chang. 2008. SNX9 regulates tubular invagination 
of the plasma membrane through interaction with actin cytoskeleton 
and dynamin 2. J. Cell Sci. 121:1252–1263. http://dx.doi.org/10.1242/ 
jcs.016709
Stinchcombe,  J.C.,  H.  Nomoto,  D.F.  Cutler,  and  C.R.  Hopkins.  1995. 
Anterograde and retrograde traffic between the rough endoplasmic retic-
ulum and the Golgi complex. J. Cell Biol. 131:1387–1401. http://dx.doi 
.org/10.1083/jcb.131.6.1387
Strizzi, L., K.M. Hardy, E.A. Seftor, F.F. Costa, D.A. Kirschmann, R.E. Seftor, 
L.M. Postovit, and M.J. Hendrix. 2009. Development and cancer: at the 
crossroads of Nodal and Notch signaling. Cancer Res. 69:7131–7134. 
http://dx.doi.org/10.1158/0008-5472.CAN-09-1199
Tarbutton,  E.,  A.A.  Peden,  J.R.  Junutula,  and  R.  Prekeris.  2005.  Class  I   
FIPs,  Rab11-binding  proteins  that  regulate  endocytic  sorting  and  re-
cycling. Methods Enzymol. 403:512–525. http://dx.doi.org/10.1016/ 
S0076-6879(05)03045-4
Townsend, T.A., J.L. Wrana, G.E. Davis, and J.V. Barnett. 2008. Transforming 
growth factor-beta-stimulated endocardial cell transformation is depen-
dent on Par6c regulation of RhoA. J. Biol. Chem. 283:13834–13841. 
http://dx.doi.org/10.1074/jbc.M710607200
Vega-Salas, D.E., P.J. Salas, and E. Rodriguez-Boulan. 1987. Modulation of the 
expression of an apical plasma membrane protein of Madin-Darby canine 
kidney epithelial cells: cell-cell interactions control the appearance of a 
novel intracellular storage compartment. J. Cell Biol. 104:1249–1259. 
http://dx.doi.org/10.1083/jcb.104.5.1249
Vieira, O.V., K. Gaus, P. Verkade, J. Fullekrug, W.L. Vaz, and K. Simons. 
2006. FAPP2, cilium formation, and compartmentalization of the api-
cal membrane in polarized Madin-Darby canine kidney (MDCK) cells. 
Proc. Natl. Acad. Sci. USA. 103:18556–18561. http://dx.doi.org/10.1073/ 
pnas.0608291103
Wang,  Q.,  W.H.  Fang,  J.  Krupinski,  S.  Kumar,  M.  Slevin,  and  P.  Kumar. 
2008a. Pax genes in embryogenesis and oncogenesis. J. Cell. Mol. Med. 
12:2281–2294. http://dx.doi.org/10.1111/j.1582-4934.2008.00427.x
Wang, Q., H.Y. Kaan, R.N. Hooda, S.L. Goh, and H. Sondermann. 2008b. 
Structure  and  plasticity  of  endophilin  and  sorting  nexin  9.  Structure. 
16:1574–1587. http://dx.doi.org/10.1016/j.str.2008.07.016
Wilson, G.M., A.B. Fielding, G.C. Simon, X. Yu, P.D. Andrews, R.S. Hames, 
A.M. Frey, A.A. Peden, G.W. Gould, and R. Prekeris. 2005. The FIP3-
Rab11 protein complex regulates recycling endosome targeting to the 
cleavage furrow during late cytokinesis. Mol. Biol. Cell. 16:849–860. 
http://dx.doi.org/10.1091/mbc.E04-10-0927